Molecular toolkit for single-cell oxi-mC analysis
用于单细胞 oxi-mC 分析的分子工具包
基本信息
- 批准号:10267182
- 负责人:
- 金额:$ 19.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-21 至 2023-09-29
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalATAC-seqAberrant DNA MethylationAdoptedAntibodiesArchitectureBiochemical ReactionBioinformaticsBiologyCarbonCardiovascular DiseasesCellsChemicalsChromatinChromatin LoopClinicalCouplingCytosineDNADNA DamageDNA MethylationDNA Modification MethylasesDNA Modification ProcessDNA ProbesDataData SetDevelopmentDioxygenasesDiseaseEpigenetic ProcessExposure toFamilyGene ExpressionGenetic TranscriptionGenomeGenomic DNAGenomic SegmentGenomicsGoalsHeterogeneityHigh-Throughput Nucleotide SequencingHomeostasisHumanIndividualInterventionKnowledgeLibrariesMalignant NeoplasmsMass Spectrum AnalysisMeasurementMeasuresMediatingMethodsModificationMolecularMolecular BiologyMolecular ConformationMonitorMusNucleotidesOligonucleotidesOxidesPathologicPlayPositioning AttributePreparationProtein translocationReactionResearchResearch PersonnelResolutionRoleSamplingSideSwitch GenesTechniquesTechnologyTestingTissuesTreatment ProtocolsVariantanalysis pipelinebasebiological systemsbiomaterial compatibilitybisulfitechemical reactioncomparison groupcomputerized data processingcostdemethylationdisease diagnosisembryonic stem cellepigenomeepigenome editingfunctional genomicsgenome integritygenome-widehuman diseaseinnovationinnovative technologiesmethyl groupoxidationresponsetechnology developmenttechnology research and developmenttool
项目摘要
Project Summary / Abstract
DNA methylation homeostasis is primarily maintained by coordinated actions of DNA
methyltransferases (DNMTs) and the Ten-eleven Translocation (TET) dioxygenase. While DNMTs
catalyze the addition of a methyl group to the carbon-5 position of cytosine to generate 5-
methylcytosine (5mC), TET proteins mediate the further oxidation of 5mC to successively yield 5-
hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). These DNA
methylation oxidation products, collectively termed as “oxi-mC”, not only serve as critical intermediates
during active DNA demethylation, but also act as important epigenetic marks to regulate gene
transcription, chromatin accessibility and 3D chromatin organization. With advanced sequencing
technology, the genomic distribution and function of individual oxi-mC species are just beginning to be
appreciated. However, our current knowledge on oxi-mC is mostly based on sequencing results from
bulk cells and tissues. A major current challenge is to efficiently probe single cell oxi-mC at single-base
resolution, and to unambiguously assign their correlations with 3D chromatin features. The existing
single cell 5hmC and 5fC mapping technologies adopt totally different strategies, including antibody-
based enrichment, chemical/enzymatic reactions, and/or bisulfite treatment. The variation in sample
treatment protocols adds tremendous complexity for library preparation and introduces significant
barriers for data processing and cross-group comparisons. By leveraging complementary expertise in
epigenetics, chemical biology and bioinformatics, the PI has assembled a strong team of investigators
to tackle this challenge. The goal of this exploratory technology development proposal is to develop an
innovative and widely applicable molecular toolset, which will enable paralleled high-resolution mapping
and analysis of individual oxi-mC heterogeneity and chromatin architectures in single cells derived from
various biological systems. Given the importance of chromatin accessible regions and long-range
chromatin loops in governing gene expression, we will focus on unraveling the functional coupling of
oxi-mC with 3D chromatin organization in these functional genomic regions. The successful execution
of this project will provide a streamlined pipeline to profile oxi-mC at single-base resolution and permit
simple side-by-side comparison of 5hmC, 5fC and 5caC dynamics. This toolkit can be widely used to
monitor oxi-mC dynamics in normal development and various pathological conditions associated with
aberrant DNA methylation, such as cardiovascular disease, immunoinflammatory disorders and cancer.
项目摘要 /摘要
DNA甲基化稳态主要通过DNA的协调作用维持
甲基转移酶(DNMTS)和十个易位(TET)二氧酶。而dnmts
催化甲基添加到胞嘧啶的碳-5位置以产生5--
TET蛋白(5MC)甲基胞嘧啶(5MC)介导5MC的进一步氧化,成功产生5--
羟基胞嘧啶(5HMC),5-甲基霉素(5FC)和5-羧基霉素(5CAC)。这些DNA
甲基化氧化产物统称为“ Oxi-MC”,不仅是关键中间体
在活性DNA脱甲基化期间,但也充当了调节基因的重要表观遗传标记
转录,染色质可及性和3D染色质组织。带有高级测序
技术,单个Oxi-MC物种的基因组分布和功能才开始成为
感谢。但是,我们目前对OXI-MC的了解主要基于
散装细胞和组织。当前的主要挑战是在单基碱基处有效探测单细胞OXI-MC
分辨率,并明确用3D染色质特征分配其相关性。现有
单细胞5HMC和5FC映射技术采用完全不同的策略,包括抗体 -
基于富集,化学/酶促反应和/或亚硫酸盐治疗。样品的变化
治疗方案增加了图书馆准备的巨大复杂性,并引入了重要的复杂性
数据处理和跨组比较的障碍。通过利用完成专业知识
PI表观遗传学,化学生物学和生物信息学,已经组建了一个强大的研究人员
应对这一挑战。该探索性技术发展建议的目的是开发
创新且广泛适用的分子刀具集,该工具集将实现并行的高分辨率映射
并分析单个细胞中单个细胞中的单个Oxi-MC异质性和染色质结构
各种生物系统。鉴于染色质访问区域和远距离的重要性
染色质循环在管理基因表达中,我们将专注于揭开功能耦合
在这些功能基因组区域中具有3D染色质组织的Oxi-MC。成功的执行
该项目将提供一个简化的管道,以在单基准分辨率下进行轮廓OXI-MC并允许
5HMC,5FC和5CAC动力学的简单并排比较。该工具包可广泛用于
监测正常发育中的Oxi-MC动力学以及与
异常的DNA甲基化,例如心血管疾病,免疫炎症疾病和癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yun Huang其他文献
Yun Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yun Huang', 18)}}的其他基金
Mutational cooperativity in TET2-associated hematological malignancies.
TET2 相关血液恶性肿瘤中的突变协同性。
- 批准号:
10209454 - 财政年份:2021
- 资助金额:
$ 19.05万 - 项目类别:
Mutational cooperativity in TET2-associated hematological malignancies.
TET2 相关血液恶性肿瘤中的突变协同性。
- 批准号:
10366080 - 财政年份:2021
- 资助金额:
$ 19.05万 - 项目类别:
Mutational cooperativity in TET2-associated hematological malignancies.
TET2 相关血液恶性肿瘤中的突变协同性。
- 批准号:
10600101 - 财政年份:2021
- 资助金额:
$ 19.05万 - 项目类别:
Molecular toolkit for single-cell oxi-mC analysis
用于单细胞 oxi-mC 分析的分子工具包
- 批准号:
10038441 - 财政年份:2020
- 资助金额:
$ 19.05万 - 项目类别:
Role of TET dioxygenase associated immune mechanisms in cardiac injury and repair
TET双加氧酶相关免疫机制在心脏损伤和修复中的作用
- 批准号:
9903438 - 财政年份:2019
- 资助金额:
$ 19.05万 - 项目类别:
Role of TET dioxygenase associated immune mechanisms in cardiac injury and repair
TET双加氧酶相关免疫机制在心脏损伤和修复中的作用
- 批准号:
10361463 - 财政年份:2019
- 资助金额:
$ 19.05万 - 项目类别:
TET-mediated epigenetic regulation in cardiac development.
TET 介导的心脏发育中的表观遗传调控。
- 批准号:
10394202 - 财政年份:2018
- 资助金额:
$ 19.05万 - 项目类别:
相似国自然基金
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
- 批准号:62302218
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:82260745
- 批准年份:2022
- 资助金额:33.00 万元
- 项目类别:地区科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:32100438
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Regulation of DNA methylation by TETs and QSER1
TET 和 QSER1 对 DNA 甲基化的调节
- 批准号:
10585325 - 财政年份:2022
- 资助金额:
$ 19.05万 - 项目类别:
Regulation of DNA methylation by TETs and QSER1
TET 和 QSER1 对 DNA 甲基化的调节
- 批准号:
10709595 - 财政年份:2022
- 资助金额:
$ 19.05万 - 项目类别:
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen
口腔共生结肠癌病原体 Parvimonas micra 致癌的表观遗传机制
- 批准号:
10693952 - 财政年份:2021
- 资助金额:
$ 19.05万 - 项目类别:
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen
口腔共生结肠癌病原体 Parvimonas micra 致癌的表观遗传机制
- 批准号:
10488196 - 财政年份:2021
- 资助金额:
$ 19.05万 - 项目类别:
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen
口腔共生结肠癌病原体 Parvimonas micra 致癌的表观遗传机制
- 批准号:
10296060 - 财政年份:2021
- 资助金额:
$ 19.05万 - 项目类别: